Patent ID: 11939333
Assignee: INFINITY PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The process of claim 9, wherein the ligand is XPhos, PCy3, PCy2Ph, PiPr3, PCy2tBu, di(1-adamantyl)-n-butylphosphine, P(MeOC6H4)3, PPh2(C6H4CO2H), PPh2(C6H4SO3H), SPhos, JohnPhos, DavePhos, MePhos, di-tert-butyl(2,2-diphenyl-1-methyl-1-cyclopropyl)phosphine, dicyclohexyl(1-methyl-2,2-diphenylvinyl)phosphine, dicyclohexyl(2,2-diphenyl-1-methyl-1-cyclopropyl)phosphine, iBu Triplecage, PtBu2Cy, PtBu3, 2-(dicyclohexylphosphino)-1-(2,4,6-trimethylphenyl)-1H-imidazole, PtBu2(PhNMe2), PPh3, dppp, dppe, dppb, BINAP, DPEPhos, dppf, dbpf, XantPhos, N-tBu2P azetine, dppm, dmpe, dippe, DIPAMP, Chiraphos, SPANphos, 5,5′-bis(diphenylphosphino)-4,4′-bi-1,3-benzodioxole, Me-DuPhos, or Josiphos.